california davis persistence stage infection great frontier area need understand federal research spending lyme modest relative diseases national institutes health budget lyme research current fiscal year $ 21 million fraction $ 186 million set aside study malaria disease certainly global health threat eradicated united states 1951 lack vaccine frustrating dead ends lyme research late 1990s food drug administration lyme disease safe effective manufacturer glaxosmithkline facing litigation citing slow sales stopped making 2002 responding increasing patient concern lyme disease u.s. house representatives passed legislation earlier month requiring better interagency coordination lyme research establishing advisory role representatives patient advocacy community physicians bill